Trifluoroacetamide

Trifluoroacetamide

SCHEMBL6991362

COc1cccc(CC(OC(=O)C(F)(F)F)C2CCNCC2)c1OC.NC(=O)C(F)(F)F

nearest known ligand 0.40

Full drug profile on Sugi Atlas →

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.36
LMNA P02545 1/20 0.36
ALDH1A1 P00352 3/20 0.36
TP53 P04637 1/20 0.36
SLC6A2 P23975 3/20 0.35
SLC6A4 P31645 3/20 0.35
KDM4E B2RXH2 2/20 0.35
PKM P14618 1/20 0.34
GNAI3 P08754 1/20 0.33
POLB P06746 1/20 0.33
SLC6A3 Q01959 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetamide SCHEMBL6993217 0.87 SLC6A2 (0.40) L3MBTL1LMNAALDH1A1TP53SLC6A2
SCHEMBL6989780 0.75 SLC6A2 (0.46) L3MBTL1LMNAALDH1A1TP53SLC6A2
Methanesulfonamide SCHEMBL6999861 0.73 CA2 (0.44) L3MBTL1LMNAALDH1A1TP53SLC6A2
SCHEMBL6999002 0.72 ALDH1A1 (0.37) L3MBTL1LMNAALDH1A1TP53PKM
SCHEMBL7904903 0.68 SLC6A2 (0.39) ALDH1A1TP53SLC6A2SLC6A4KDM4E
SCHEMBL6992863 0.65 L3MBTL1 (0.45) L3MBTL1LMNAALDH1A1KDM4EPOLB
SCHEMBL13701328 0.65 GNAI3 (0.47) L3MBTL1ALDH1A1SLC6A2SLC6A4KDM4E
Trifluoroacetic Acid SCHEMBL29579487 0.64 HTR2A (0.51) LMNAALDH1A1TP53SLC6A4KDM4E
Trifluoroacetic Acid SCHEMBL22118447 0.64 HTR2A (0.51) LMNAALDH1A1TP53SLC6A4KDM4E
SCHEMBL23216868 0.64 SLC6A4 (0.40) SLC6A2SLC6A4SLC6A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1015446-B1 (4-PIPERIDINYL)-1H-2-BENZOPYRAN DERIVATIVES USEFUL AS ANTIPSYCHOTIC AGENTS AVENTIS PHARMA INC (US) 2003-04-02 EP disclosed
US-6004982-A SIDE EFFECT REDUCTION; SCHIZOPHRENIA HOECHST MARION ROUSSEL, INC. (US) 1999-12-21 US disclosed